这是一篇来自已证抗体库的有关
人类 IL 23 (IL 23) 的综述，是根据12篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合IL 23 抗体。
IL 23 同义词: IL-23; IL-23A; IL23P19; P19; SGRF
赛默飞世尔
| 小鼠 单克隆（HNU2319） | | 赛默飞世尔IL 23抗体（eBioscience, HNU2319)被用于被用于抑制或激活实验在人类样本上 (图 3d). Eur J Immunol (2016) ncbi |
| 小鼠 单克隆（C8.6） | - 抑制或激活实验; 人类; 10 ug/ml; 图 3
| 赛默飞世尔IL 23抗体（eBioscience, C8.6)被用于被用于抑制或激活实验在人类样本上浓度为10 ug/ml (图 3). J Immunol (2015) ncbi |
| 小鼠 单克隆（C8.6） | | 赛默飞世尔IL 23抗体（eBioscience, C8.6)被用于被用于抑制或激活实验在人类样本上浓度为2.5 ug/ml. J Immunol (2014) ncbi |
| 小鼠 单克隆（HNU2319） | | 赛默飞世尔IL 23抗体（eBioscience, HNU2319)被用于被用于抑制或激活实验在人类样本上. Eur J Immunol (2015) ncbi |
| 小鼠 单克隆（C8.6） | | 赛默飞世尔IL 23抗体（eBioscience, C8.6)被用于被用于抑制或激活实验在人类样本上. Eur J Immunol (2015) ncbi |
| 小鼠 单克隆（C8.6） | | 赛默飞世尔IL 23抗体（eBioscience, C8.6)被用于被用于抑制或激活实验在人类样本上浓度为10 ug/ml. PLoS ONE (2014) ncbi |
| 小鼠 单克隆（C8.6） | | 赛默飞世尔IL 23抗体（eBioscience, C8.6)被用于被用于流式细胞仪在人类样本上浓度为1 ug/ml (图 3). PLoS ONE (2013) ncbi |
| 小鼠 单克隆（C8.6） | | 赛默飞世尔IL 23抗体（eBioscience, C8.6)被用于被用于抑制或激活实验在人类样本上. Int Immunol (2006) ncbi |
| 小鼠 单克隆（C8.6） | | 赛默飞世尔IL 23抗体（Endogen, C8.6)被用于被用于酶联免疫吸附测定在人类样本上 (表 1). Transplant Proc (2003) ncbi |
艾博抗（上海）贸易有限公司
| domestic rabbit 多克隆 | - 免疫组化-石蜡切片; 人类; 1:200; 图 2a
| 艾博抗（上海）贸易有限公司IL 23抗体（Abcam, ab45420)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 2a). Exp Ther Med (2021) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司IL 23抗体（Abcam, ab45420)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 s4a). Cell (2017) ncbi |
圣克鲁斯生物技术
| 小鼠 单克隆（D-12） | | 圣克鲁斯生物技术IL 23抗体（Santa Cruz, 271349)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 7a). Arthritis Res Ther (2022) ncbi |
ProSci
| domestic rabbit 多克隆 | | ProSciIL 23抗体（ProSci incorporated, 3795)被用于被用于免疫组化-石蜡切片在小鼠样本上 (图 5d). J Exp Med (2016) ncbi |
Zhang L, Zheng D, Yan Y, Yu Y, Chen R, Li Z,
et al. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis. Arthritis Res Ther. 2022;24:148
pubmed 出版商 Dai Z, Ma X, Yang R, Wang H, Xu D, Yang J,
et al. Intestinal flora alterations in patients with ulcerative colitis and their association with inflammation. Exp Ther Med. 2021;22:1322
pubmed 出版商 Kortlever R, Sodir N, Wilson C, Burkhart D, Pellegrinet L, Brown Swigart L,
et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression. Cell. 2017;171:1301-1315.e14
pubmed 出版商 Yoon J, Leyva Castillo J, Wang G, Galand C, Oyoshi M, Kumar L,
et al. IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization. J Exp Med. 2016;213:2147-66
pubmed 出版商 Cheng W, van Asten S, Burns L, Evans H, Walter G, Hashim A,
et al. Periodontitis-associated pathogens P. gingivalis and A. actinomycetemcomitans activate human CD14(+) monocytes leading to enhanced Th17/IL-17 responses. Eur J Immunol. 2016;46:2211-21
pubmed 出版商 Tsai C, Liong K, Gunalan M, Li N, Lim D, Fisher D,
et al. Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus. J Immunol. 2015;194:3890-900
pubmed 出版商 Lim D, Yawata N, Selva K, Li N, Tsai C, Yeong L,
et al. The combination of type I IFN, TNF-α, and cell surface receptor engagement with dendritic cells enables NK cells to overcome immune evasion by dengue virus. J Immunol. 2014;193:5065-75
pubmed 出版商 de Groen R, Boltjes A, Hou J, Liu B, McPhee F, Friborg J,
et al. IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells. Eur J Immunol. 2015;45:250-9
pubmed 出版商 Deng N, Weaver J, Mosmann T. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+IFN?- Thpp cells. PLoS ONE. 2014;9:e95986
pubmed 出版商 Nagy L, Grishina I, Macal M, Hirao L, Hu W, Sankaran Walters S,
et al. Chronic HIV infection enhances the responsiveness of antigen presenting cells to commensal Lactobacillus. PLoS ONE. 2013;8:e72789
pubmed 出版商 Gorski K, Waller E, Bjornton Severson J, Hanten J, Riter C, Kieper W,
et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol. 2006;18:1115-26
pubmed Meloni F, Cascina A, Paschetto E, Marone Bianco A, Morosini M, Pellegrini C,
et al. Monocyte chemoattractant protein-1 levels in bronchoalveolar lavage fluid of lung-transplanted patients treated with tacrolimus as rescue treatment for refractory acute rejection. Transplant Proc. 2003;35:1523-6
pubmed
